4.3 Article

Relationship Between Episodic Nocturnal Hypercapnia and History of Exacerbations in Patients with Advanced Chronic Obstructive Disease

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/COPD.S361914

关键词

episodic nocturnal hypercapnia; sleep-associated hypoventilation; exacerbations; arterial carbon dioxide pressure; rapid eye movement

向作者/读者索取更多资源

This study aimed to investigate the relationship between episodic nocturnal hypercapnia (eNH) and COPD exacerbation. The results showed that eNH may be associated with a history of more frequent exacerbations in COPD patients with a daytime arterial carbon dioxide pressure (PaCO2) < 55.0 mmHg.
Purpose: An episodic increase in transcutaneous carbon dioxide pressure (PtcCO(2)) is often recognized in patients with advanced chronic obstructive pulmonary disease (COPD) by overnight PtcCO(2) monitoring. This phenomenon, called episodic nocturnal hypercapnia (eNH), mainly corresponds to rapid eye movement (REM) sleep-related hypoventilation. However, it is unclear whether eNH is associated with the frequency of COPD exacerbation. We aimed to investigate whether a relationship exists between COPD exacerbation and eNH. Patients and Methods: We enrolled consecutive patients with stable, severe, or very severe COPD with a daytime arterial carbon dioxide pressure (PaCO2) < 55.0 mmHg who underwent overnight PtcCO(2) monitoring from April 2013 to January 2017. We retro-spectively analyzed the prevalence of eNH and sleep-associated hypoventilation (SH) as defined by the American Academy of Sleep Medicine. Moreover, we compared the relationship between the frequency of COPD exacerbations in the previous year and eNH or SH. Results: Twenty-four patients were included in this study. The study patients had a mean daytime PaCO(2 )and nocturnal PtcCO(2) of 43.3 +/- 6.8 mmHg and 42.9 +/- 9.6 mmHg, respectively. Six (25.0%) and 11 (45.9%) of the 24 patients met the SH and eNH criteria, respectively. The odds ratios of SH and eNH for at least one annual exacerbation were 1.0 [95% confidence interval (CI): 0.16-6.00] and 11.1 [95% CI: 1.39-87.7], respectively. The odds ratios of SH and eNH for at least two annual exacerbations were 0.3 [95% CI: 0.04-2.64] and 6.6 [95% CI: 1.06-39.4], respectively. Conclusion: In patients with advanced COPD and a daytime PaCO2 < 55.0 mmHg, eNH may be associated with a history of more frequent exacerbations than SH. Further studies are required to validate these findings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据